Amerikanische Gesellschaft für Hirudotherapie

Combinatorial Evolution of Enzymes and Synthetic Pathways Using One-Step PCR

Synthetic biology paper published in ACS Synthetic Biology (2016)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)ArzneimittelentwicklungGenomik & ProteomikJin P et al. · ACS Synthetic Biology, 2016

Abstract

DNA engineering is the fundamental motive driving the rapid development of modern biotechnology. Here, we present a versatile evolution method termed "rapidly efficient combinatorial oligonucleotides for directed evolution" (RECODE) for rapidly introducing multiple combinatorial mutations to the target DNA by combined action of a thermostable high-fidelity DNA polymerase and a thermostable DNA Ligase in one reaction system. By applying this method, we rapidly constructed a variant library of the rpoS promoters (with activity of 8-460%), generated a novel heparinase from the highly specific leech hyaluronidase (with more than 30 mutant residues) and optimized the heme biosynthetic pathway by combinatorial evolution of regulatory elements and pathway enzymes (2500 ± 120 mg L(-1) with 20-fold increase). The simple RECODE method enabled researchers the unparalleled ability to efficiently create diverse mutant libraries for rapid evolution and optimization of enzymes and synthetic pathways.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAmino Acid SequenceAnimalsBase SequenceCloning, MolecularDNA LigasesDNA-Directed DNA PolymeraseDirected Molecular EvolutionGenetic EngineeringHeparin LyaseHyaluronoglucosaminidaseLeechesMolecular Sequence Data

Zusammenfassung

RECODE one-step PCR enzyme evolution method generated a novel heparinase from highly specific leech hyaluronidase via more than 30 mutant residues — repurposing a leech salivary enzyme into a different antithrombotic biopharmaceutical raw material.

Warum dies für die Hirudotherapie relevant ist

This methodological study presents RECODE, a method for introducing combinatorial mutations into target DNA using a thermostable high-fidelity DNA polymerase and a thermostable DNA ligase in one reaction system. Among its demonstrations, the authors generated a novel heparinase from leech hyaluronidase through directed evolution involving more than 30 mutant residues. For ASH, this illustrates the use of leech hyaluronidase as a starting scaffold for enzyme engineering. CAVEAT: This is a genetic engineering methodology paper with no clinical or therapeutic leech therapy content; leech hyaluronidase serves only as a protein template, and findings are biochemical with no direct hirudotherapy relevance.

Zitation

Combinatorial Evolution of Enzymes and Synthetic Pathways Using One-Step PCR.

Jin P et al. · ACS Synthetic Biology, 2016

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.